To promote and sustain the successful commercialization process and the NHP industry, the consortium will emphasize the development of innovative technology and processes for the production of unique cultivars and their subsequent intellectual property "branding" based on their unique genomic, phytochemical and pharmacological/biological characteristics. The release of registered IP-protected cultivars will provide Ontario growers with quality and marketing advantages over global competitors. Intellectual property protection for novel phytochemicals shown to have pharmacological effects will stimulate the NHP industry in Ontario.
For a list of recent publications, click here.
Dr. David Sharp - UWO, Ivey Business School
Naturex - leading producer of plant extracts
Jamieson Laboratories - Canadian producer of vitamins and natural health products